BPC2001
/ BioPhoenix
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 25, 2025
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
(clinicaltrials.gov)
- P2 | N=50 | Recruiting | Sponsor: BioPhoenix Co., Ltd.
New P2 trial • Acute Graft versus Host Disease • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology • Transplantation
1 to 1
Of
1
Go to page
1